2-86790578-C-A

Variant summary

Our verdict is Benign. The variant received -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2

The NM_001768.7(CD8A):​c.153G>T​(p.Thr51Thr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00513 in 1,612,602 control chromosomes in the GnomAD database, including 30 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0030 ( 2 hom., cov: 33)
Exomes 𝑓: 0.0053 ( 28 hom. )

Consequence

CD8A
NM_001768.7 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -3.22

Publications

1 publications found
Variant links:
Genes affected
CD8A (HGNC:1706): (CD8 subunit alpha) The CD8 antigen is a cell surface glycoprotein found on most cytotoxic T lymphocytes that mediates efficient cell-cell interactions within the immune system. The CD8 antigen acts as a coreceptor with the T-cell receptor on the T lymphocyte to recognize antigens displayed by an antigen presenting cell in the context of class I MHC molecules. The coreceptor functions as either a homodimer composed of two alpha chains or as a heterodimer composed of one alpha and one beta chain. Both alpha and beta chains share significant homology to immunoglobulin variable light chains. This gene encodes the CD8 alpha chain. Multiple transcript variants encoding different isoforms have been found for this gene. The major protein isoforms of this gene differ by the presence or absence of a transmembrane domain and thus differ in being a membrane-anchored or secreted protein. [provided by RefSeq, May 2020]
CD8A Gene-Disease associations (from GenCC):
  • susceptibility to respiratory infections associated with CD8alpha chain mutation
    Inheritance: AR Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet, ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -17 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.58).
BP6
Variant 2-86790578-C-A is Benign according to our data. Variant chr2-86790578-C-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 464445.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-3.22 with no splicing effect.
BS2
High Homozygotes in GnomAd4 at 2 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CD8ANM_001768.7 linkc.153G>T p.Thr51Thr synonymous_variant Exon 2 of 6 ENST00000283635.8 NP_001759.3 P01732-1Q6ZVS2Q8TAW8

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CD8AENST00000283635.8 linkc.153G>T p.Thr51Thr synonymous_variant Exon 2 of 6 1 NM_001768.7 ENSP00000283635.3 P01732-1

Frequencies

GnomAD3 genomes
AF:
0.00306
AC:
466
AN:
152178
Hom.:
2
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00128
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00183
Gnomad ASJ
AF:
0.000866
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.000621
Gnomad FIN
AF:
0.000754
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00541
Gnomad OTH
AF:
0.000956
GnomAD2 exomes
AF:
0.00310
AC:
759
AN:
244788
AF XY:
0.00312
show subpopulations
Gnomad AFR exome
AF:
0.000835
Gnomad AMR exome
AF:
0.000638
Gnomad ASJ exome
AF:
0.000703
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00162
Gnomad NFE exome
AF:
0.00582
Gnomad OTH exome
AF:
0.00314
GnomAD4 exome
AF:
0.00534
AC:
7802
AN:
1460306
Hom.:
28
Cov.:
34
AF XY:
0.00524
AC XY:
3809
AN XY:
726522
show subpopulations
African (AFR)
AF:
0.00102
AC:
34
AN:
33476
American (AMR)
AF:
0.000514
AC:
23
AN:
44704
Ashkenazi Jewish (ASJ)
AF:
0.000498
AC:
13
AN:
26104
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39698
South Asian (SAS)
AF:
0.00114
AC:
98
AN:
86234
European-Finnish (FIN)
AF:
0.00156
AC:
81
AN:
52070
Middle Eastern (MID)
AF:
0.000347
AC:
2
AN:
5762
European-Non Finnish (NFE)
AF:
0.00657
AC:
7310
AN:
1111890
Other (OTH)
AF:
0.00399
AC:
241
AN:
60368
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
501
1002
1504
2005
2506
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
280
560
840
1120
1400
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00305
AC:
464
AN:
152296
Hom.:
2
Cov.:
33
AF XY:
0.00279
AC XY:
208
AN XY:
74474
show subpopulations
African (AFR)
AF:
0.00127
AC:
53
AN:
41582
American (AMR)
AF:
0.00183
AC:
28
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.000866
AC:
3
AN:
3466
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5176
South Asian (SAS)
AF:
0.000622
AC:
3
AN:
4824
European-Finnish (FIN)
AF:
0.000754
AC:
8
AN:
10616
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.00538
AC:
366
AN:
68006
Other (OTH)
AF:
0.000946
AC:
2
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.514
Heterozygous variant carriers
0
25
50
76
101
126
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00418
Hom.:
0
Bravo
AF:
0.00300
Asia WGS
AF:
0.000577
AC:
2
AN:
3478
EpiCase
AF:
0.00403
EpiControl
AF:
0.00545

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Feb 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

CD8A: BP4, BP7, BS2 -

Susceptibility to respiratory infections associated with CD8alpha chain mutation Benign:1
Jan 29, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

CD8A-related disorder Benign:1
Jul 03, 2019
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.58
CADD
Benign
0.80
DANN
Benign
0.65
PhyloP100
-3.2
PromoterAI
0.038
Neutral
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs147048705; hg19: chr2-87017701; API